Literature DB >> 6286070

Calcium in excitation--contraction coupling of frog skeletal muscle.

S R Taylor, J R Lopez, P J Griffiths, G Trube, G Cecchi.   

Abstract

A principal step in the process leading to muscle contraction is the intracellular release of Ca2+. We have detected and compared some physical and chemical events that reflect Ca2+ release in contracting frog skeletal muscle cells, described the effects of some agents that are believed to alter intracellular Ca2+ release during contraction, and speculated about the role of Ca2+ release in influencing some of the mechanical properties of frog muscle. The specific physical features recorded were changes in striation spacing, myofibrillar orientation, and force development. The chemical feature was the relative change in intracellular [Ca2+] recorded as light emission from cells microinjected with the Ca2+-sensitive protein aequorin. The presence or absence of a correlation among these variables has been used (i) to evaluate the action of some agents thought to change intracellular Ca2+ release in excitation--contraction (E--C) coupling, (ii) to further substantiate the effects of cell length on Ca2+ release, and (iii) to examine some details of models for E--C coupling. The results showed that potentiating agents enhance and prolong intracellular Ca2+ release without changing the rate of Ca2+ removal during E--C coupling. This extra Ca2+ does not produce the same effect on contractions at all lengths. Contractility is inversely related to cell length, and Ca2+-induced activation is normally less than maximum not only at short lengths but also at optimal striation spacings.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286070     DOI: 10.1139/y82-068

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  11 in total

1.  Histochemical and physiological properties of Rana temporaria tibialis anterior and lumbricalis IV muscle fibres.

Authors:  P A Iaizzo
Journal:  J Muscle Res Cell Motil       Date:  1990-08       Impact factor: 2.698

2.  Effects of rapid shortening on rate of force regeneration and myoplasmic [Ca2+] in intact frog skeletal muscle fibres.

Authors:  R Vandenboom; D R Claflin; F J Julian
Journal:  J Physiol       Date:  1998-08-15       Impact factor: 5.182

3.  Isometric muscle contractions after double pulse stimulation. comparison of healthy subjects and patients with myotonic dystrophy.

Authors:  U Dillmann; H C Hopf; G Lüder; K Schimrigk
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  Sarcomere length dependence of the force-velocity relation in single frog muscle fibers.

Authors:  H L Granzier; D H Burns; G H Pollack
Journal:  Biophys J       Date:  1989-03       Impact factor: 4.033

5.  The effects of temperature on relaxation in frog skeletal muscle: the role of parvalbumin.

Authors:  P A Iaizzo
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

6.  Specialized contacts between sarcolemma and sarcoplasmic reticulum at the ends of muscle fibers in the diaphragm of the rat.

Authors:  D P Andreev; W A Wassilev
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

Review 7.  Length dependence of changes in sarcoplasmic calcium concentration and myofibrillar calcium sensitivity in striated muscle fibres.

Authors:  D G Stephenson; I R Wendt
Journal:  J Muscle Res Cell Motil       Date:  1984-06       Impact factor: 2.698

8.  Drosophila calmodulin mutants with specific defects in the musculature or in the nervous system.

Authors:  Bo Wang; Kathleen M C Sullivan; Kathy Beckingham
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

9.  Paralysis of frog skeletal muscle fibres by the calcium antagonist D-600.

Authors:  R S Eisenberg; R T McCarthy; R L Milton
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

10.  Effect of tetanus duration on the free calcium during the relaxation of frog skeletal muscle fibres.

Authors:  M B Cannell
Journal:  J Physiol       Date:  1986-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.